Biotech Values

[DewDiligence]

Re: Zetia vs Niaspan

Merck is preparing to defend its drug, said Chief Executive Officer Richard T. Clark. Doctors shouldn’t change how they treat patients based on the findings, he said.

If this is not an admission that Niaspan won, I’m not sure what it is.